During the past decade, Landeskrankenhaus Feldkirch conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Landeskrankenhaus Feldkirch" #1 collaborator was "Bristol-Myers Squibb" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Landeskrankenhaus Feldkirch" are "Acute Myeloid Leukemia (AML)" (1 trials), "Carcinoma, Pancreatic Ductal" (1 trials), "Higher Risk Myelodysplastic Syndromes (MDS With Excess Blasts 2)" (1 trials), "Melanoma" (1 trials) and "Melanoma (Skin)" (1 trials). Many other conditions were trialed in "Landeskrankenhaus Feldkirch" in a lesser frequency.

Most popular intervention types in "Landeskrankenhaus Feldkirch" are "Biological" (1 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Bempegaldesleukin" (1 trials), "Gemcitabine" (1 trials), "Nab-paclitaxel" (1 trials), "Napabucasin" (1 trials) and "Nivolumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Landeskrankenhaus Feldkirch" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Landeskrankenhaus Feldkirch". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Landeskrankenhaus Feldkirch, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Landeskrankenhaus Feldkirch, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".